Neuronetics Inc. (STIM) Prices 4.84M Share Common Offering at $15.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
After-Hours Stock Movers 01/28: (KOSS) (GME) (NVAX) Higher; (EVLO) (ADMP) (JNP) Lower (more...)
January 28, 2021 6:00 PM ESTToday's After-Hours Stock Movers:
Koss Corporation (NASDAQ: KOSS) 47.9% HIGHER; Robinhood will again allow limited trades
GameStop Corp. (NYSE: GME) 35% HIGHER; Robinhood will again allow limited trades
Novavax, Inc. (Nasdaq: NVAX) 29% HIGHER; announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical... More
Neuronetics (STIM) Announces Proposed Public Offering of Common Stock
January 28, 2021 4:02 PM ESTNeuronetics, Inc. (NASDAQ: STIM) (the Company), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has commenced an underwritten public offering of its... More
Neuronetics (STIM) PT Raised to $23 at JMP Securities
January 27, 2021 2:42 AM ESTJMP Securities analyst David Turkaly raised the price target on Neuronetics (NASDAQ: STIM) to $23.00 (from $15.00) while maintaining a Market Outperform rating.... More



